--- title: "Keen Vision Acquisition | 10-Q: FY2025 Q2 EPS: USD 0.2" type: "News" locale: "en" url: "https://longbridge.com/en/news/252546283.md" datetime: "2025-08-11T20:01:55.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/252546283.md) - [en](https://longbridge.com/en/news/252546283.md) - [zh-HK](https://longbridge.com/zh-HK/news/252546283.md) generator: "portal-rs" --- # Keen Vision Acquisition | 10-Q: FY2025 Q2 EPS: USD 0.2 EPS: As of FY2025 Q2, the actual value is USD 0.2. ### Segment Revenue - **Dividend Income**: For the six months ended June 30, 2025, dividend income earned in investments held in the Trust Account was $1,489,599, compared to $3,530,524 for the same period in 2024. ### Operational Metrics - **Net Income**: For the six months ended June 30, 2025, net income was $1,126,226, compared to $5,040,728 for the same period in 2024. - **Formation and Operating Costs**: For the six months ended June 30, 2025, formation and operating costs were - $363,373, compared to - $533,783 for the same period in 2024. ### Cash Flow - **Net Cash Used in Operating Activities**: For the six months ended June 30, 2025, net cash used in operating activities was - $486,853, compared to - $370,399 for the same period in 2024. - **Net Cash Used in Investing Activities**: For the six months ended June 30, 2025, net cash used in investing activities was - $1,200,000. - **Net Cash Provided by Financing Activities**: For the six months ended June 30, 2025, net cash provided by financing activities was $1,633,622. ### Future Outlook and Strategy - **Core Business Focus**: The company is focused on completing a business combination by August 27, 2025, with the possibility of extending the deadline further. The company has entered into a merger agreement with Medera Inc., a clinical stage biopharmaceutical company, with a net value of $622,560,000 for Medera’s shares. - **Non-Core Business**: The company has not commenced any operations and is focused on identifying a potential target for a business combination. The company will not generate operating revenues until after the completion of a business combination. ### Related Stocks - [KVAC.US](https://longbridge.com/en/quote/KVAC.US.md) - [KVACF.US](https://longbridge.com/en/quote/KVACF.US.md) ## Related News & Research - [Trump: will not allow companies to build data centers outside US](https://longbridge.com/en/news/306311996.md) - [Is it time to buy at the bottom? Jensen Huang is still being smeared. Anthropic's IPO = a horror story.](https://longbridge.com/en/news/306347695.md) - [Anthropic CEO vacations at Italian resort after public listing](https://longbridge.com/en/news/306344644.md) - [Claude helped Anthropic's Levent Alpöge crack the Riemann hypothesis, he claims](https://longbridge.com/en/news/306339966.md) - [How Biden’s former aide sparked a $100bn stock market sell-off](https://longbridge.com/en/news/306364454.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**